Real-life persistence and tolerability with dimethyl fumarate

Background Dimethyl fumarate (DMF) has been registered for the treatment of relapsing-remitting multiple sclerosis (RRMS). Differences in tolerability between multiple sclerosis clinics in patients treated with DMF has not been examined. Aim We examined real-world tolerability to DMF, and also compared adherence data between two MS clinics. Methods Adverse events (AE), discontinuation rates, and causes of discontinuation were investigated....